Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04637594
Title Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Alliance for Clinical Trials in Oncology
Indications

urethra transitional cell carcinoma

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

Therapies

Durvalumab

Nivolumab

Atezolizumab

Avelumab

Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.